disease progression

Type: Keyphrase
Name: disease progression
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Efficacy of Second-Line Oxaliplatin, Leucovorin, and Fluorouracil in Patients With Gemcitabine-Refractory Pancreatic Cancer

Share this article:Efficacy of Second-Line Oxaliplatin, Leucovorin, and Fluorouracil in Patients With Gemcitabine-RefraAccording to a new study published in the Journal of Clinical Oncology , second-line oxaliplatin, leucovorin (folinic acid), and fluorouracil ... [Published Chemotherapy Advisor - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

New therapy helps people with Parkinson's

- 13 WTHR IndianapolisNew therapy helps people with Parkinson'sThere's a new therapy that's helping people with Parkinson's disease.It's making their day-to-day lives a little easier, and even slowing the progression of the disease.62-year-old Todd Hebb ... [Published WTHR - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Blood Pressure, Brain Structure, and Cognition: Opposite Associations in Men and Women

BACKGROUNDResearch on associations between blood pressure, brain structure, and cognitive function has produced somewhat inconsistent results. In part, this may be due to differences in age ranges studied and because of sex differences in physiology and/or ... [Published American Journal of Hypertension - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study

MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, ... [Published PR Newswire: Health - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

The role of microglial activation in disease progression

Microglia, a unique type of myeloid cell, play a key role in the inflammation-mediated neurodegeneration occurring during both acute and chronic stages of multiple sclerosis (MS). These highly specialized cells trigger neurotoxic pathways, producing ... [Published Multiple Sclerosis Journal current issue - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Eyes are window into dementia

A new study has found that changes in the eye could help predict dementia, even before the symptoms show.According to the researchers from Gladstone Institutes and University of California, San Francisco, loss of cells in the retina could be used as an ... [Published Business Standard India - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

HIV Superinfection Apparently Doesn’t Affect Disease Progression

ViiV's New HIV Drug ApprovedA complete guide to the fixed-dose combination tablet Triumeq ("Trii").Mistaken IdentityHIV can disguise itself as bacteria and evade antibodies.Beyond Blame, Populations and PrEPAn analysis of the themes at the 20th International ... [Published AIDSmeds - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

PSA density predicts progression of low-risk prostate cancer during active surveillance

ORLANDO – Prostate-specific antigen density, total number of biopsies, and later year of diagnosis were significantly associated with disease progression in men under active surveillance for low-risk... ... [Published Oncology Report - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

There's still hunger for 'blockbuster' biotech deals

It's been a record year for health-care mergers and acquisitions. But the traditional targets—biotech companies—haven't been the main event, as buyers have increasingly looked for overseas acquisitions in tax inversion strategies."While health-care M&A ... [Published CNBC - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Researchers investigate origins of MS to target treatment

Researchers at Hofstra Northshore-LIJ School of Medicine have found the origins of the cell believed to cause multiple sclerosis (MS).In a study published in Science Translational Medicine, researchers investigated B cells, a type of immune cell believed ... [Published FOXNews.com - Aug 25 2014]
First reported Aug 24 2014 - Updated Aug 24 2014 - 1 reports

Diet, lifestyle choices help maintain retina health

By DR. NANCY BONACHEARetina Vision CenterSince the finest vessels in the human body are found in retinal tissue, risk factors affecting circulation include high blood pressure and cholesterol, diabetes mellitus and smoking. Diet, lifestyle and medication ... [Published Union Leader - Aug 24 2014]
First reported Aug 22 2014 - Updated Aug 23 2014 - 3 reports

Health Highlights: Aug. 22, 2014-August 22, 2014

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:Ice Bucket Challenge Has Raised $41 Million for ALS ResearchMore than $41 million has been raised to fight amyotrophic lateral sclerosis (ALS) -- commonly ... [Published InteliHealth - Aug 22 2014]

Quotes

...of these antibodies against HIV isolated from the persistent viral reservoir and their likely long-circulating half-lives," they continued. "With the possibility of biochemical modification allowing for a more prolonged plasma half-life, it is conceivable that HIV-infected individuals could potentially maintain very low or undetectable plasma viremia in the absence of ART following relatively infrequent administration of these antibodies."
...this is a very important clue, that an immune response produced by bone marrow transplantation has such a strong anti-HIV effect," Cooper added. "We're going to use this as a model for cure research and see if we can develop some therapies that mimic what were doing with bone marrow transplantation."
...Mice that were fed the spice showed better brain function and motor skills, which are often affected in Parkinson's patients. "This could potentially be one of the safest approaches to halt disease progression in Parkinson's patients" said Floyd A Davis, professor of neurology at Rush University
...According to news originating from Woodcliff Lake, New Jersey , by NewsRx correspondents, research stated, "The symptomatic drugs currently on the market for Alzheimer's disease (AD) have no effect on disease progression, and this creates a large unmet medical need. The type of drug that has developed most rapidly in the last decade is immunotherapy: vaccines and, especially, passive vaccination with monoclonal antibodies."

More Content

All (758) | News (638) | Reports (0) | Blogs (108) | Audio/Video (0) | Fact Sheets (1) | Press Releases (3)
sort by: Date | Relevance
Diet High In Salt Can Worsen MS Symptoms And In... [Published Medical Daily - 4 hours ago]
Study: Androgen inhibitor reduces death risk by... [Published Urology Times - 5 hours ago]
Vaccine boosts advanced NSCLC patient survival [Published News-Medical.Net - 6 hours ago]
CPE Monthly: Curcumin and Inflammatory Diseases [Published Today's Dietitian - 7 hours ago]
Broadly Neutralizing Antibodies May Prevent Res... [Published HIV and Hepatitis.com - 7 hours ago]
Differential Responses of Cecal Microbiota to F... [Published Plosone.org - 8 hours ago]
Visceral Leishmaniasis and HIV Coinfection: Tim... [Published Plosone.org - 8 hours ago]
Possible Role of Interleukin-1β in Type 2 Diabe... [Published Plosone.org - 8 hours ago]
Early Mucosal Sensing of SIV Infection by Panet... [Published Plosone.org - 9 hours ago]
AIDS 2014: Australian Bone Marrow Transplant Pa... [Published HIV and Hepatitis.com - 9 hours ago]
Ice Bucket Challenge puts focus on ALS [Published Caribbean Camera - 14 hours ago]
Parkinson's Breakthrough: Researchers Discover ... [Published NewsMax.com - 14 hours ago]
Myriad Genetics to Present at the Morgan Stanle... [Published Scottrade - 16 hours ago]
Early-Stage Minimally-Invasive Biomarkers in Al... [Published Global Information Inc - 21 hours ago]
New Genetics and Alzheimer Disease Study Result... [Published HispanicBusiness.com - Aug 28 2014]
Intel’s new Parkinson’s monitoring technology e... [Published Nigeria Daily Independent - Aug 28 2014]
Study Data from Central Hospital Update Knowled... [Published 4 Traders - Aug 28 2014]
Idaho State U. Prof. Jean Pfau identifies possi... [Published Prlog - Aug 28 2014]
Efficacy of Second-Line Oxaliplatin, Leucovorin... [Published Chemotherapy Advisor - Aug 27 2014]
New therapy helps people with Parkinson's [Published WTHR - Aug 27 2014]
Advancing against ALS [Published Drug Discovery News - Aug 27 2014]
Safety First: BAT Leads Call on Harm... [Published tobacco asia - Aug 27 2014]
Blood Pressure, Brain Structure, and Cognition:... [Published American Journal of Hypertension - Aug 27 2014]
Novel Biomarker Detects Early Rheumatoid Arthri... [Published Minyanville - Aug 27 2014]
Novel Biomarker Detects Early Rheumatoid Arthri... [Published PR Newswire: Health - Aug 27 2014]
Targeted therapy one step closer in neuroblasto... [Published Medical Xpress - Aug 27 2014]
The Promising Role of IoT and Big Data in Parki... [Published Intel - Aug 27 2014]
With An Iffy Non-Oncology Pipeline, Roche Pays ... [Published Seeking Alpha - Aug 27 2014]
Novel equation to determine the hepatic triglyc... [Published 7thSpace - Aug 26 2014]
Addiction and survival with HIV [Published CATIE - Aug 26 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Novel Biomarker Detects Early Rheumatoid Arthri... [Published PR Newswire: Health - Aug 27 2014]
MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, ...
The role of microglial activation in disease pr... [Published Multiple Sclerosis Journal current issue - Aug 26 2014]
Microglia, a unique type of myeloid cell, play a key role in the inflammation-mediated neurodegeneration occurring during both acute and chronic stages of multiple sclerosis (MS). These highly specialized cells trigger neurotoxic pathways, producing ...
Teva: putting its money where its mouth is [Published Multiple Sclerosis Research - Aug 25 2014]
Laquinimod gets a vote of confidence as Teva take it into Huntington's disease. #MSBlog #MSResearch "You have heard me get excited on this blog about the potential of laquinimod to be the ultimate add-on DMT for MS. Laquinimod appears to work downstream ...
Back to the Stone Age [Published Multiple Sclerosis Research - Aug 20 2014]
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, ...
What Are Wearable Devices Really Capable Of? [Published Wall St. Cheat Sheet - Aug 19 2014]
We’ve all heard the phrases “wearable technology” and “wearable devices” tossed around as tech enthusiasts get more excited about the potential for small sensors and electronics packed into a sporty watch or wristband to track our fitness and health ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
StemCells, Inc. Interim Results Show Improvemen... [Published GlobeNewswire: Advertising News - Jun 19 2014]
NeuroPhage to Participate in World's First G8 D... [Published PR Newswire - Dec 03 2013]
Revalesio Initiates Phase IIa Study of RNS60 in... [Published PR Newswire - Nov 11 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.